Skip to main content
Premium Trial:

Request an Annual Quote

InDevR, St. Jude Collaborate to Evaluate Influenza Test

NEW YORK (GenomeWeb) – InDevR this week announced a collaboration with St. Jude Children's Research Hospital's Richard Webby on the development of a diagnostic test for influenza. 

Webby's laboratory will help the Boulder, Colorado-based firm develop its FluChip-8G, a microarray-based clinical test for genotyping influenza viruses. InDevR signed a $14.7 million contract with the Biomedical Advanced Research and Development Authority about a year ago to finish developing the test.

Webby is an expert on influenza and director of the World Health Organization Collaborating Center for Studies on the Ecology of Influenza in Animals and Birds at St. Jude. As part of its collaboration with InDevR, Webby's lab will evaluate the performance of FluChip-8G on non-seasonal influenza viruses. 

If cleared by the US Food and Drug Administration, FluChip-8G will enable physicians to rapidly distinguish between seasonal and potential pandemic non-season influenza viruses such as H5N1 and H7N9, InDevR said.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.